Denovo生物创新公司获得了2.4M美元的资金,用于推进其外科机器人手术,以关闭伤口。 Denovo Bioinnovations secures $2.4M funding to advance its surgical robotics for wound closure.

Denovo生物创新项目是2020年创立的手术机器人创业项目,已获得由校园天使网络牵头的1.96克罗尔资金。 Denovo Bioinnovations, a surgical robotics startup founded in 2020, has secured ₹1.96 Crore in funding led by Campus Angels Network. 这些资金将支持其产品Suture Sure和LapSure的商业化,Suture和LapSure利用先进技术改进伤口结扎,使手术更加有效和精确。 The funds will support the commercialization of its products, SutureSure and LapSure, which use advanced technology to improve wound closure, making surgeries more efficient and precise. 该公司的目标是进入一个360亿美元的全球市场,在全世界推广保健解决方案。 The company aims to enter a $36 billion global market, advancing healthcare solutions worldwide.